Top experts by indication / Oncology
Most active experts in Prostate Cancer
2026 edition, data as of October 26, 2026
412 key opinion leaders in the directory are tagged to Prostate Cancer. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 336 of the 412 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Karim FizaziCentre Oscar Lambret | 16 trials |
| 2 | Mary-Ellen TaplinMA | 15 trials |
| 3 | Mark SteinColumbia University Irving Medical Center, NY | 14 trials |
| 4 | Tomasz BeerExact Sciences Corporation, OR | 14 trials |
| 5 | Scott TagawaWeill Cornell Medicine, NY | 14 trials |
| 6 | Michael CarducciJohns Hopkins University School of Medicine, MD | 14 trials |
| 7 | James GulleyNational Cancer Institute, MD | 13 trials |
| 8 | Christopher LogothetisThe University of Texas MD Anderson Cancer Center, TX | 13 trials |
| 9 | Douglas McNeelUniversity of Wisconsin-Madison School of Medicine and Public Health, WI | 13 trials |
| 10 | Neal ShoreCarolina Urologic Research Center, SC | 12 trials |
| 11 | Elisabeth HeathMayo Clinic, MN | 12 trials |
| 12 | Eric SmallUniversity of California, San Francisco, CA | 11 trials |
| 13 | Samuel DenmeadeJohns Hopkins University School of Medicine, MD | 11 trials |
| 14 | Michael ZelefskyNYU Langone Health, NY | 11 trials |
| 15 | Rana McKayUniversity of California, San Diego, CA | 10 trials |
| 16 | Ravi MadanDC | 10 trials |
| 17 | Glenn LiuUniversity of Wisconsin Carbone Cancer Center, WI | 10 trials |
| 18 | Matthew RettigUniversity of California, Los Angeles, CA | 10 trials |
| 19 | Matthew SmithUniversity of Michigan, MA | 10 trials |
| 20 | William DahutDC | 9 trials |
| 21 | Celestia HiganoWA | 9 trials |
| 22 | Tanya DorffCity of Hope, CA | 9 trials |
| 23 | Primo LaraUniversity of California, Davis, CA | 9 trials |
| 24 | Amar KishanUniversity of California, Los Angeles, CA | 9 trials |
| 25 | Jacek PinskiUniversity of Southern California (USC), CA | 9 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 99 of the 412 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Howard ScherMemorial Sloan Kettering Cancer Center, NY | 133,670 citations |
| 2 | Fred SaadCentre hospitalier de l'Université de Montréal (CHUM) | 109,700 citations |
| 3 | Shahrokh ShariatMedical University of Vienna, NY | 100,789 citations |
| 4 | Philip KantoffMemorial Sloan Kettering Cancer Center, NY | 91,232 citations |
| 5 | Christopher LogothetisThe University of Texas MD Anderson Cancer Center, TX | 87,786 citations |
| 6 | Kenneth PientaJohns Hopkins University School of Medicine, MD | 84,965 citations |
| 7 | Karim FizaziCentre Oscar Lambret | 84,733 citations |
| 8 | David SolitMemorial Sloan Kettering Cancer Center, NY | 82,661 citations |
| 9 | Brian RiniVanderbilt University Medical Center, TN | 78,561 citations |
| 10 | Cora SternbergCornell University, NY | 73,928 citations |
| 11 | Eric SmallUniversity of California, San Francisco, CA | 69,136 citations |
| 12 | Mitesh BoradMayo Clinic, AZ | 60,996 citations |
| 13 | John HainsworthSarah Cannon Research Institute, TN | 58,030 citations |
| 14 | Michael CarducciJohns Hopkins University School of Medicine, MD | 56,123 citations |
| 15 | Shalender BhasinBrigham and Women's Hospital, MA | 55,514 citations |
| 16 | Jonathan RosenbergMemorial Sloan Kettering Cancer Center, NY | 51,894 citations |
| 17 | Ethan BaschNY | 50,818 citations |
| 18 | Charles LoprinziMayo Clinic, MN | 49,105 citations |
| 19 | Glenn BubleyBeth Israel Deaconess Medical Center, MA | 47,102 citations |
| 20 | Neal ShoreCarolina Urologic Research Center, SC | 46,560 citations |
| 21 | Mario EisenbergerJohns Hopkins University School of Medicine, MD | 45,578 citations |
| 22 | Oliver SartorEast Jefferson General Hospital Cancer Center (LCMC Health) | 45,528 citations |
| 23 | Silvia FormentiWeill Cornell Medicine, NY | 44,129 citations |
| 24 | Stephen FreedlandCedars-Sinai Medical Center | 43,632 citations |
| 25 | Michael ZelefskyNYU Langone Health, NY | 40,594 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 88 of the 412 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Shalender BhasinBrigham and Women's Hospital, MA | 26 awards |
| 2 | David SolitMemorial Sloan Kettering Cancer Center, NY | 14 awards |
| 3 | Evanthia GalanisMayo Clinic, MN | 13 awards |
| 4 | Aminah JatoiMayo Clinic, MN | 13 awards |
| 5 | George WildingWI | 12 awards |
| 6 | Charles BennettIL | 11 awards |
| 7 | Stephen FreedlandCedars-Sinai Medical Center | 9 awards |
| 8 | Andrew KraftSC | 9 awards |
| 9 | Matthew RettigUniversity of California, Los Angeles, CA | 9 awards |
| 10 | Steven ClintonThe Ohio State University, OH | 9 awards |
| 11 | Michael CarducciJohns Hopkins University School of Medicine, MD | 9 awards |
| 12 | Douglas McNeelUniversity of Wisconsin-Madison School of Medicine and Public Health, WI | 9 awards |
| 13 | Tomasz BeerExact Sciences Corporation, OR | 8 awards |
| 14 | Samuel DenmeadeJohns Hopkins University School of Medicine, MD | 7 awards |
| 15 | Walter StadlerCity of Hope, IL | 6 awards |
| 16 | Primo LaraUniversity of California, Davis, CA | 6 awards |
| 17 | Silvia FormentiWeill Cornell Medicine, NY | 6 awards |
| 18 | David NanusWeill Cornell Medicine, NY | 5 awards |
| 19 | Glenn BubleyBeth Israel Deaconess Medical Center, MA | 5 awards |
| 20 | Kenneth PientaJohns Hopkins University School of Medicine, MD | 5 awards |
| 21 | Howard ScherMemorial Sloan Kettering Cancer Center, NY | 4 awards |
| 22 | David QuinnCA | 4 awards |
| 23 | Chong-Xian PanMA | 4 awards |
| 24 | Jeff MichalskiWashington University School of Medicine in St. Louis, MO | 4 awards |
| 25 | Susan KnoxCA | 4 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 38 of the 412 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Erika HamiltonSarah Cannon Research Institute, TN | 364 contributions |
| 2 | David SolitMemorial Sloan Kettering Cancer Center, NY | 278 contributions |
| 3 | Primo LaraUniversity of California, Davis, CA | 264 contributions |
| 4 | James GulleyNational Cancer Institute, MD | 255 contributions |
| 5 | Cora SternbergCornell University, NY | 229 contributions |
| 6 | Elisabeth HeathMayo Clinic, MN | 228 contributions |
| 7 | Mehmet BilenEmory University, GA | 228 contributions |
| 8 | Timothy YapThe University of Texas MD Anderson Cancer Center, TX | 221 contributions |
| 9 | Tanya DorffCity of Hope, CA | 219 contributions |
| 10 | Charles RyanMemorial Sloan Kettering Cancer Center, MN | 198 contributions |
| 11 | John HainsworthSarah Cannon Research Institute, TN | 194 contributions |
| 12 | Tomasz BeerExact Sciences Corporation, OR | 187 contributions |
| 13 | Michael ZelefskyNYU Langone Health, NY | 175 contributions |
| 14 | Mario EisenbergerJohns Hopkins University School of Medicine, MD | 157 contributions |
| 15 | Robert DreicerUniversity of Virginia School of Medicine, VA | 156 contributions |
| 16 | Kenneth PientaJohns Hopkins University School of Medicine, MD | 154 contributions |
| 17 | Silvia FormentiWeill Cornell Medicine, NY | 153 contributions |
| 18 | Lawrence FongFred Hutchinson Cancer Center, WA | 147 contributions |
| 19 | Christopher LogothetisThe University of Texas MD Anderson Cancer Center, TX | 144 contributions |
| 20 | Charles LoprinziMayo Clinic, MN | 131 contributions |
| 21 | Leonard ApplemanUniversity of Pittsburgh, PA | 125 contributions |
| 22 | Kevin CamphausenNational Cancer Institute (NCI), MD | 120 contributions |
| 23 | Saby GeorgeRoswell Park Comprehensive Cancer Center, NY | 115 contributions |
| 24 | Terence FriedlanderUniversity of California, San Francisco, CA | 110 contributions |
| 25 | Matthew RettigUniversity of California, Los Angeles, CA | 99 contributions |
Emerging
12 of the 412 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Ana AparicioThe University of Texas MD Anderson Cancer Center, TX |
| Steven BalkBeth Israel Deaconess Medical Center, MA |
| Grace BlitzerUniversity of Wisconsin System, WI |
| Anna EisensteinYale School of Medicine, CT |
| Mayer FishmanTampa General Hospital, FL |
| Matthew HadfieldBrown University, RI |
| Comron HassanzadehThe University of Texas MD Anderson Cancer Center, TX |
| Samir KhleifGeorgetown University School of Medicine, GA |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Karie RuncieWeill Cornell Medicine, NY |
| Marina SharifiUniversity of Wisconsin System, WI |
| Sandra SilbermanNC |
How these tables are computed
The cohort is every profile in the directory tagged to Prostate Cancer, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Prostate Cancer profile in the directory